Sotera Health Announces First-Quarter 2022 Earnings Release Date
CLEVELAND, April 21, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization...
Day: April 21, 2022
Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
NEW YORK, April 21, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
Codexis and seqWell Announce Strategic Investment and Partnership Initiation
seqWell raises $7M Series C funding, led by CodexisCurrent investors Research Corporation Technologies and BroadOak Capital Partners also participated in...
MS Million Dollar Tower Challenge Aims to Raise $4m for MS Research by Sending More Than 140 Donors Rappelling Off Toronto Office Tower
Photo of 700 University Avenue, Toronto Photo of 700 University Avenue, TorontoTORONTO, April 21, 2022 (GLOBE NEWSWIRE) -- The Multiple...
Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics
Strengthens Management Team and Positions the Company for Growth and Expansion New York, NY, and Tel Aviv, ISRAEL, April 21,...
Arbutus to Report First Quarter 2022 Financial Results and Provide Corporate Update
WARMINSTER, Pa., April 21, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive...
Alignment Healthcare to Announce First Quarter 2022 Financial Results and Host Conference Call Thursday, May 5, 2022
ORANGE, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled...
InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
Expands rare cannabinoid portfolio beyond current CBC and CBTReleases White Paper outlining research into the therapeutic potential of CBDVVANCOUVER, British...
Chalice Brands Ltd. Announces Execution of Definitive Agreements to Acquire Oregon Retail Stores and Cultivation Assets
PORTLAND, Ore., April 21, 2022 (GLOBE NEWSWIRE) -- Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a...
OncXerna Therapeutics Announces Journal of Clinical Oncology Publication Featuring Phase 1b Data of Navicixizumab Plus Paclitaxel in Ovarian Cancer
Overall response rate (ORR) of 43% and median duration of response of 6 months seen with navicixizumab-paclitaxel combination in heavily...
Brooklyn ImmunoTherapeutics Announces Establishment of New Research and Development Facility for Advancement of Engineered Cellular Medicines
Company has expanded team with scientific hires who hold research expertise in stem cells, synthetic RNA, nanoparticle delivery systems and...
VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications
Arena Pharmaceuticals and Actelion veteran brings deep industry experience as VectivBio prepares for key upcoming catalystsBASEL, Switzerland, April 21, 2022 (GLOBE...
CareDx Supports UC Davis Health Pluralist Program Aimed at Reducing Health Disparities in Organ Transplantation
SOUTH SAN FRANCISCO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on...
The Joint Corp. to Host Conference Call on Thursday, May 5th to Discuss First Quarter 2022 Results
SCOTTSDALE, Ariz., April 21, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care...
BioCryst to Report First Quarter 2022 Financial Results on May 5
RESEARCH TRIANGLE PARK, N.C., April 21, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company...
Apellis Announces Results from New Global Survey Conducted by The Harris Poll Revealing the Emotional Burden and Impact on Independence Caused by Geographic Atrophy (GA)
Nearly seven in ten GA patients believe the impact on their independence and quality of life due to their visual...
Zynerba Pharmaceuticals Announces Presentation of Poster at the 2022 Society of Biological Psychiatry Annual Meeting
DEVON, Pa., April 21, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid...
Agios to Webcast Conference Call of First Quarter 2022 Financial Results on May 5, 2022
CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular...
MeMed to Host Webinar on Best Practice Clinical Use of MeMed BV® for Differentiating Viral from Bacterial Infections on April 28, 2022
HAIFA, Israel, April 21, 2022 – MeMed (or “the Company”), a leader in the emerging field of advanced host-response technologies,...
Spine Injury Solutions Appoints Robert Brilon as a New Member of the Board of Directors and Roy Bao as its Chief Technology Officer
Costa Mesa, CA, April 21, 2022 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (the “Company”), a global technology solution provider...
